BOX WARNING Drug Dependence
Ritalin LA should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and psychological dependence with varying degrees of abnormal behavior. Frank psychotic episodes can occur, especially with parenteral abuse. Careful supervision is required during withdrawal from abusive use, since severe depression may occur. Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder that may require follow-up.
|
| |
RITALIN LA SUMMARY
Ritalin® LA
Methylphenidate hydrochloride is a central nervous system (CNS) stimulant.
Ritalin LA® (methylphenidate hydrochloride) extended-release capsules is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
|
RITALIN LA NEWS HIGHLIGHTS Media Articles Related to Ritalin LA (Methylphenidate)
US FDA Approves 30-Minute Onset Of Action For Focalin(R) XR, Bringing Potential Benefits To ADHD Patients During Early Morning Period
Source: ADHD News From Medical News Today [2008.11.13]
Published Studies Related to Ritalin LA (Methylphenidate)
Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study. [2008.08]
[Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children] [2008.08]
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. [2008.06]
Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. [2008.06]
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. [2008.06]
Clinical Trials Related to Ritalin LA (Methylphenidate)
A Comparative Effectiveness Study Evaluating OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children [Completed]
An Effectiveness and Safety Study Evaluating OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder [Completed]
A Double-Blind Randomized, Placebo-Controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-Acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults [Completed]
A Multicenter Study Comparing the Efficacy and Safety of OROS® Methylphenidate HCl, Ritalin® (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder [Completed]
Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate [Completed]
|
RITALIN LA PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 1 ratings/reviews, Ritalin LA has an overall score of 8. The effectiveness score is 8 and the side effect score is 8. The scores are on ten point scale: 10 - best, 1 - worst.
| | Ritalin LA review by 41 year old female patient | | | Rating |
| Overall rating: | |   |
| Effectiveness: | | Considerably Effective |
| Side effects: | | Mild Side Effects | | |
Treatment Info |
| Condition / reason: | | ADHD |
| Dosage & duration: | | 30mg taken 1 for the period of 1 yr |
| Other conditions: | | Depression |
| Other drugs taken: | | Cymbalta | | |
Reported Results |
| Benefits: | | This medication enabled me to think clearly. My thought processes were more coherent. It assisted me in concentrating and therefore I was able to complete tasks --- finally had follow-thru! I was able to manage my time better. |
| Side effects: | | This medication caused me to be nervous, tremble and I became slightly irritable. |
| Comments: | | n/a |
|
|
|
Page last updated: 2008-11-13
|
